|
|
Previous Article | Table of Contents | Next Article 
Murine JAK3 is preferentially expressed in hematopoietic tissues and
lymphocyte precursor cells
CB Gurniak and LJ Berg
Department of Molecular and Cellular Biology, Harvard University,
Cambridge, MA 02138, USA.
To elucidate the role of cytokine receptor signal transduction in T- cell
development, we have investigated the expression pattern and biochemical
characteristics of the murine Janus family tyrosine kinase, JAK3. Previous
studies have shown that JAK3 is expressed in lymphoid and myeloid tumor
cell lines and in a small number of lymphoid tissues. To further
characterize JAK3 expression, we used a quantitative polymerase chain
reaction approach to compare JAK3 mRNA levels at multiple stages of T-cell
differentiation and in a broad range of mouse tissues. These studies, in
conjunction with analyses of JAK3 protein expression, show that the highest
levels of JAK3 are in adult, 2-week- old, and fetal thymus, followed by
somewhat lower levels in bone marrow, spleen, fetal liver, and adult
CD4-CD8- thymocytes. We also show that different forms of JAK3 mRNA arise
by alternative splicing. Finally, our biochemical studies show that the
JAK3 kinase domain, but not the pseudo-kinase domain, has tyrosine kinase
activity and, furthermore, that JAK3 kinase activity is abolished by an
amino acid substitution of the conserved lysine in the kinase domain
(K851R). These studies show that JAK3 expression is profoundly skewed to
hematopoietic and lymphoid precursor cells, strongly suggesting a role for
JAK3 in hematopoiesis and T- and B-cell development.
Volume 87,
Issue 8,
pp. 3151-3160,
04/15/1996
Copyright © 1996 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Lague and J. J. Tremblay
Antagonistic Effects of Testosterone and the Endocrine Disruptor Mono-(2-Ethylhexyl) Phthalate on INSL3 Transcription in Leydig Cells
Endocrinology,
September 1, 2008;
149(9):
4688 - 4694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Mangan, S. G. Rane, A. D. Kang, A. Amanullah, B. C. Wong, and E. P. Reddy
Mechanisms associated with IL-6-induced up-regulation of Jak3 and its role in monocytic differentiation
Blood,
June 1, 2004;
103(11):
4093 - 4101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Roberts, A. Lengi, S. M. Brown, M. Chen, Y.-J. Zhou, J. J. O'Shea, and R. H. Buckley
Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation
Blood,
March 15, 2004;
103(6):
2009 - 2018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Aringer, S. R. Hofmann, D. M. Frucht, M. Chen, M. Centola, A. Morinobu, R. Visconti, D. L. Kastner, J. S. Smolen, and J. J. O'Shea
Characterization and Analysis of the Proximal Janus Kinase 3 Promoter
J. Immunol.,
June 15, 2003;
170(12):
6057 - 6064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chen, A. Cheng, F. Candotti, Y.-J. Zhou, A. Hymel, A. Fasth, L. D. Notarangelo, and J. J. O'Shea
Complex Effects of Naturally Occurring Mutations in the JAK3 Pseudokinase Domain: Evidence for Interactions between the Kinase and Pseudokinase Domains
Mol. Cell. Biol.,
February 1, 2000;
20(3):
947 - 956.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Friedrich, W. Kammer, I. Erhardt, S. Brandlein, W. Sebald, and R. Moriggl
Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation
Int. Immunol.,
August 1, 1999;
11(8):
1283 - 1294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Bunting, K. J. Flynn, J. M. Riberdy, P. C. Doherty, and B. P. Sorrentino
Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency
PNAS,
January 5, 1999;
96(1):
232 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lischke, R. Moriggl, S. Brandlein, S. Berchtold, W. Kammer, W. Sebald, B. Groner, X. Liu, L. Hennighausen, and K. Friedrich
The Interleukin-4 Receptor Activates STAT5 by a Mechanism That Relies upon Common gamma -Chain
J. Biol. Chem.,
November 20, 1998;
273(47):
31222 - 31229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Goodman, L. B. Niehoff, and F. M. Uckun
Role of Tyrosine Kinases in Induction of the c-jun Proto-oncogene in Irradiated B-lineage Lymphoid Cells
J. Biol. Chem.,
July 10, 1998;
273(28):
17742 - 17748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Smithgall
Signal Transduction Pathways Regulating Hematopoietic Differentiation
Pharmacol. Rev.,
March 1, 1998;
50(1):
1 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Sohn, K. A. Forbush, N. Nguyen, B. Witthuhn, T. Nosaka, J. N. Ihle, and R. M. Perlmutter
Requirement for Jak3 in Mature T Cells: Its Role in Regulation of T Cell Homeostasis
J. Immunol.,
March 1, 1998;
160(5):
2130 - 2138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dalal, E. Arpaia, H. Dadi, S. Kulkarni, J. Squire, and C. M. Roifman
Cloning and Characterization of the Human Homolog of Mouse Jak2
Blood,
February 1, 1998;
91(3):
844 - 851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-J. Zhou, E. P. Hanson, Y.-Q. Chen, K. Magnuson, M. Chen, P. G. Swann, R. L. Wange, P. S. Changelian, and J. J. O'Shea
Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity
PNAS,
December 9, 1997;
94(25):
13850 - 13855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chen, A. Cheng, Y.-Q. Chen, A. Hymel, E. P. Hanson, L. Kimmel, Y. Minami, T. Taniguchi, P. S. Changelian, and J. J. O'Shea
The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals
PNAS,
June 24, 1997;
94(13):
6910 - 6915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. H. Chen, B. K.R. Patel, L.-M. Wang, M. Frankel, N. Ellmore, R. A. Flavell, W. J. LaRochelle, and J. H. Pierce
Jak1 Expression Is Required for Mediating Interleukin-4-induced Tyrosine Phosphorylation of Insulin Receptor Substrate and Stat6 Signaling Molecules
J. Biol. Chem.,
March 7, 1997;
272(10):
6556 - 6560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Thomis and L. J. Berg
Peripheral Expression of Jak3 Is Required to Maintain T Lymphocyte Function
J. Exp. Med.,
January 20, 1997;
185(2):
197 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Kammer, A. Lischke, R. Moriggl, B. Groner, A. Ziemiecki, C. B. Gurniak, L. J. Berg, and K. Friedrich
Homodimerization of Interleukin-4 Receptor alpha Chain Can Induce Intracellular Signaling
J. Biol. Chem.,
September 27, 1996;
271(39):
23634 - 23637.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|